Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s market research analyst predicts that the global western blotting market will grow at a CAGR of nearly 6% during the forecast period. Western blotting, also known as protein blotting, is a technique used to identify specific amino-acid sequences in proteins. This technique is being widely used in Proteomics, which is the study of protein structure and functions. Western blotting simplifies functional analyses of proteins and is effective in understanding cell signaling molecules. It also examines the differential expression and post-translational modifications like glycosylation and phosphorylation activities. The recent increase in investments in the R&D of proteomic technologies to develop reliable and accurate solutions has led to an increase in the usage of western blotting.
In 2015, the Americas was the largest geographical segment accounting for a total market share of over 49%. With the high prevalence of HIV/AIDS, the US is expected to dominate the global western blotting market during the forecast period. Several awareness programs have been undertaken by the global organizations, providing huge funds, across regions, to deal with HIV/AIDS cases. Such initiatives will lead to the increase in medical research; thereby, leading to the growth of the western blotting market. In addition, most of the R&D centres of pharmaceutical and biotechnology companies located in this region have developed vaccinations to treat for HIV/AIDS. Furthermore, the National Institutes of Health (NIH) have allocated significant funds to the Americas to carry out research in the field of biotechnology, focusing on human health.
The global western blotting market is characterized by the presence of many international and regional vendors. The international vendors have a strong hold over the market, making it difficult for local vendors to compete, especially in terms of quality and pricing. With the increase in the number of laboratories along with rapid technological advances, the competition between the vendors is likely to intensify during the forecast period. Furthermore, many dominant vendors are shifting their R&D and manufacturing facilities to APAC, owing to the low cost of land and labor available.
Key vendors in the market are -
Other prominent vendors in the market are Abcam, Advansta, AMRESCO, Azure Biosystems, Cell Signaling Technology, Cygnus, KOMA BIOTECH, KPL, Kirkegaard & Perry Laboratories, LI-COR, Lumigen, PerkinElmer, Protein Simple, Roche Diagnostics, and Rockland Immunochemicals.
The consumables segment is expected to dominate the western blotting market during the forecast period and is estimated to be valued at about USD 481 million by 2020. The repeated purchase of reagents by various end users like diagnostic laboratories have resulted in the steady growth of the market. Also, the rapid technological advances related to manual and fully-automated western blot instruments have led to the high demand for reagents to detect proteins with high sensitivity and stability.
The pharmaceutical and biotechnology company segment is dominated the western blotting market during the forecast period and accounted for a total market share of more than 43% in 2015. The western blotting technique is widely used in fields like food and beverage and agriculture, which allows the pharmaceutical and biotechnology companies to make high investments on R&D. For instance, Teva Pharmaceuticals and Biogen focus on developing drugs using western blotting testing.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end-user
PART 08: Geographical segmentation
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
PART 17: Explore Technavio
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.